Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 9 (2), 25

Review of the Treatment Options for Chronic Constipation

Affiliations
Review

Review of the Treatment Options for Chronic Constipation

John F Johanson. MedGenMed.

Abstract

Constipation is a common gastrointestinal motility disorder that is often chronic, negatively affects patients' daily lives, and is associated with high healthcare costs. There is a considerable range of treatment modalities available for patients with constipation; however, the clinical evidence supporting their use varies widely. Nonpharmacologic modalities, such as increased exercise or fluid intake and bowel habit training, are generally recommended as first-line approaches, but data on the effectiveness of these measures are limited. The clinical benefits of various traditional pharmacologic agents (many of which are available over the counter, such as laxatives and fiber supplements) remain unclear. Although these modalities may benefit some patients with temporary constipation, their efficacy in patients for whom constipation is chronic is less well defined. Some studies suggest benefit with psyllium, polyethylene glycol, and lactulose; however, the use of other agents, such as calcium polycarbophil, methylcellulose, bran, magnesium hydroxide, and stimulant laxatives, is not supported by strong clinical evidence. More recently, newer agents have been approved for the treatment of patients with chronic constipation on the basis of comprehensive clinical investigation programs. Tegaserod, with its well-established clinical profile, and lubiprostone, the latest addition to the treatment armamentarium, represent the new generation of therapies for chronic constipation. This article reviews the efficacy and safety of traditional therapies used in the management of the multiple symptoms associated with chronic constipation and discusses recently approved and emerging therapies for this disorder.

Figures

Figure 1
Figure 1
Diagnostic/treatment algorithm for constipation. CBC = complete blood count; GI = gastrointestinal; IBD = inflammatory bowel disease; IBS = irritable bowel syndrome; TSH = thyroid-stimulating hormone. Modified from Hunt R, Lacy B. Diagnosis and management of chronic constipation in the primary care setting. Intern Med World Rep. 2004;1(suppl):3-23 with permission from Ascend Media Healthcare.
Figure 2
Figure 2
Tegaserod (6 mg BID) responders for increased complete spontaneous bowel movements (CSBMs). Percentage of patients experiencing an increase of 1 or more CSBMs per week during weeks 1-4 (primary efficacy variable). BID = twice daily

Comment in

Similar articles

  • Treating Chronic Constipation : How Should We Interpret the Recommendations?
    DA Johnson. Clin Drug Investig 26 (10), 547-57. PMID 17163288. - Review
    Chronic constipation is a multisymptom gastrointestinal motility disorder that negatively impacts the lives of those affected. New recommendations on diagnosing and treat …
  • Constipation in the Elderly: Management Strategies
    G Spinzi et al. Drugs Aging 26 (6), 469-74. PMID 19591521. - Review
    Constipation is a highly prevalent and bothersome disorder that negatively affects patients' social and professional lives and places a great economic burden on both pati …
  • [Therapeutic Options of Chronic Constipation]
    H Krammer et al. Internist (Berl) 46 (12), 1331-8. PMID 16283137. - Review
    Chronic constipation is a widespread disease affecting up to 25 percent of the population in western countries. The symptoms associated with constipation may lead to a he …
  • Management of Constipation in Older Adults
    A Mounsey et al. Am Fam Physician 92 (6), 500-4. PMID 26371734.
    Chronic constipation is common in adults older than 60 years, and symptoms occur in up to 50% of nursing home residents. Primary constipation is also referred to as funct …
  • Management of Chronic Constipation in Patients With Diabetes Mellitus
    VG Prasad et al. Indian J Gastroenterol 36 (1), 11-22. PMID 27987136. - Review
    The primary aim of intervention in diabetic patients with chronic constipation is to better manage the diabetes along with management of constipation. The physician shoul …
See all similar articles

Cited by 21 PubMed Central articles

See all "Cited by" articles

Publication types

Feedback